About this trial
Colorectal cancer frequently presents with liver metastases, and complete removal of both primary and liver tumors can significantly improve survival. Simultaneous resection (SA) of the colon and liver is increasingly used and is considered safe when minor liver resections are performed, offering advantages such as shorter hospitalization, fewer complications, and faster chemotherapy initiation.
However, the best sequence of resection, liver-first or colon-first, remains uncertain, as each has potential benefits and drawbacks, particularly regarding anastomotic healing. Minimally invasive approaches to SA show similar outcomes to open surgery, though limited data suggest that resection order may affect blood loss.
Eligibility criteria
Qualifiers
Adult patients diagnosed with colorectal cancer with synchronous liver metastases during the reference period, who underwent simultaneous resection.
Disqualifiers
Simultaneous emergency resection due to symptoms of the primary tumor.
Presence of extrahepatic metastatic disease confirmed at the time of resection or diagnosis.
High surgical risk defined as an ASA risk score greater than 3.
At least 10 cases performed by the invited center during the study period.
Trial design
Treatments tested in this trial
- Data collection